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Introduction
Intraoperative transesophageal echocardiography (TEE) during 
general anesthesia for cardiac surgery is nowadays considered 
routine in cardiac centers and recommended by guidelines.1 It 
allows surgical teams to tailor therapeutic interventions and to 
control the success of surgical interventions. In a relevant num-
ber of cases, unexpected valvular lesions or dysfunctions are 
identified by intraoperative TEE (up to 15%–30%) and often 
lead to a change in surgical strategy.2,3 When looking for evi-
dence on how to manage “new” intraoperative TEE findings, 
recommendations for the management of several “single” val-
vular lesions offer guidance, whereas for numerous constella-
tions involving more than one valve, the perioperative specialist 
team still cannot revert to robust guidelines.4 In these cases, 
clinical judgment must be used when tailoring management to 
multiple lesions, comorbidities, frailty, and overall prognosis of 
an individual patient.5–7
This case of a patient with three combined regurgitant 
valvular lesions, one of them not described as severe before, 
elucidates intraoperative time-critical decision-making con-
cerning the surgical strategy.
Case report
A 61-year-old female with a history of intravenous drug 
abuse (IVDA) presented in a septic state with dyspnea. Her 
history included recurrent systemic infective episodes from 
IV puncture sites and chronic dermal ulcers, which led to 
right-sided infective endocarditis (IE) 27 years ago with 
remaining severe tricuspid regurgitation (TR). Anemia 
(hemoglobin 7.9 g/dL) and chronic kidney disease (creati-
nine 1.88 mg/dL and eGFR 31 mL/min) were also present. A 
presumptive diagnosis of recurrent IE was made.
On admission, transthoracic echocardiography (TTE) and 
a subsequent TEE revealed severe aortic regurgitation (AR) 
from a flail non-coronary cusp (Classification of regurgita-
tion according to American Society of Echocardiography), 
with vegetations on all three cusps (Figure 1; Clips 1 and 2 in 
Supplemental Material).4 Whereas tricuspid and mitral valve 
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(MV) were both without apparent vegetations. Pre-existing 
severe TR was confirmed, and severe mitral regurgitation 
(MR) was noted in TEE (Figure 2(a); Clip 3 in Supplemental 
Material). Biventricular function was preserved; however, the 
left ventricle (LV) was dilated (left ventricular end-diastolic 
inner diameter (LVEDD) of 65 mm). A coronary computed 
tomography angiogram described no stenotic lesions. Blood 
cultures returned positive for Serratia marcescens. Despite a 
given indication for early surgery, valve surgery was deferred 
until her poor overall medical state had improved to the point 
where high-risk cardiac surgery could be discussed with her.8 
After a total of 3 weeks of appropriate antibiotic therapy, a 
TTE exam confirmed the findings of the initial echocardiog-
raphy studies except for a now mild MR (Clip 4 in 
Supplemental Material) with a dilated LV (LVEDD 58 mm; 
blood pressure 123 mm Hg systolic, 56 mm Hg diastolic, and 
78 mm Hg mean arterial pressure; heart rate 99/min). The 
patient was scheduled for combined aortic valve (AV) 
Figure 1. Transesophageal echocardiography (TEE) midesophageal aortic valve long-axis view showing aortic valve endocarditis with 
perforated cusp and severe aortic regurgitation.
Figure 2. (a) Initial transesophageal echocardiography (TEE) zoomed midesophageal 4-chamber (ME-4CH) view showing moderate 
mitral regurgitation (MR) (zoomed recording resized to match scale of Panel b). (b) Initial intraoperative TEE vena contracta (VC) 
measurement of severe MR in ME-4CH view before surgery. (c): Intraoperative TEE after aortic valve replacement (AVR) and 
cardiopulmonary bypass (CPB). (d): Postoperative transthoracic echocardiography (TTE) apical 4-chamber view with mild MR (4 months 
after AVR).
LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle.
Friess et al. 3
replacement (biological prosthesis) and tricuspid valve (TV) 
repair.
After an uneventful induction of anesthesia, the intraop-
erative initial TEE exam confirmed vegetations on all three 
AV cusps, the presence of severe AR, and also its mechanism 
as described in the preoperative exam. In contrast to the lat-
est preoperative TTE exam, the initially performed intraop-
erative TEE revealed severe-grade MR (vena contracta 
(VC), 8 mm; PISA method quantification: effective regurgi-
tant orifice area (EROA), 0.55 cm2; regurgitant volume, 
63 mL, all measured in midesophageal long axis view), with 
a dense and notching regurgitant jet (Figures 2(b) and 3; Clip 
5 in Supplemental Material).4 Left cavities were dilated 
(LVEDD, 62 mm; MV diameter, 38 mm ME commissural 
view, 27 mm ME LAX view) but left ventricular function 
was preserved (Clip 6 in Supplemental Material). The mech-
anism of MR appeared mixed, as there was malcoaptation 
(Carpentier’s Classification IIIb) but also some thickening of 
both leaflets. No vegetations, perforations, leaflet prolapsed, 
or flail were seen on the MV apparatus. At the time of this 
exam, the blood pressure was normal (125 mm Hg systolic, 
50 mm Hg diastolic, and 75 mm Hg mean arterial pressure, 
heart rate 73 per minute).
Interdisciplinary discussion of the new finding arrived at 
the decision to continue with the planned double-valve pro-
cedure, that is, aortic valve replacement (AVR) and TV 
repair, in line with class I guideline recommendations.6,9 
Given the patient’s poor general condition and numerous 
comorbidities, one important aspect was to limit time on car-
diopulmonary bypass (CPB) to the necessary minimum. 
Although severe AR appeared as primary cause for volume 
overload of the LV, with the latter mechanism aggravating 
severe MR, it remained uncertain at that point whether cor-
rection of AR would also significantly reduce severity of 
MR.
The decision was to test MV function during reperfusion 
after AVR and TV repair, before considering a triple valve 
procedure. Indeed, TEE on partial CPB during reperfusion as 
well as after complete weaning from CPB showed sustained 
improvement of the formerly severe- to mild-grade MR 
(Figure 2; Clip 7 in Supplemental Material), this classifica-
tion also held true when the MV was carefully challenged 
with elevated afterload by norepinephrine (100 mm Hg sys-
tolic, 56 mm Hg diastolic, and 70 mm Hg mean arterial pres-
sure, heart rate 89 per minute). Two postoperative follow-up 
echocardiograms confirmed the presence of a merely mild 
MR (one 6 days and the other exam 4 months after surgery, 
Figure 2, each with normal blood pressures and heart rates).
Postoperative recovery was complicated by an episode of 
atrial flutter but otherwise uneventful. Kidney function 
improved after surgery (creatinine 108 μmol/L and eGFR 
51 mL/min on the day before discharge) without any need for 
dialysis. The patient was discharged home 3 weeks after car-
diac surgery.
Discussion
In patients with severe AR, concomitant moderate-to-severe 
MR is not uncommon. Its prevalence amounted to 25% in a 
large retrospective database analysis, and appeared indepen-
dently associated with reduced survival.5,10 In a small subset 
of patients with AR (n = 65), MV repair (but not replace-
ment) in combination with AVR was associated with 
improved survival.10 However, literature on the natural his-
tory of MR in the setting of surgical or transfemoral AVR is 
focused on aortic stenosis as the leading lesion. But even 
there, the development of MR after AVR is not always 
toward an “intuitive” improvement of MR and the fate of 
MR remains uncertain.11,12
Guideline recommendations for surgical treatment of val-
vular heart disease mostly refer to single valve lesions.6,13 
Multiple-valve disease (mVD) is covered by recommenda-
tions merely in the context of chronic secondary MR or TR 
at the time of other cardiac surgery, and mostly with C level 
evidence.6,9 However, multiple-valvular lesions, especially 
when affecting the same (left) chamber, are hemodynami-
cally interdependent and presumably interact in remodeling 
and reverse remodeling of the LV.
This case of left-sided IE with severe AR in a patient with 
IVDA showed a rather rapid deterioration from mild- to 
severe-grade MR. The patient’s clinical course, however, did 
not give any hints for an acute deterioration but had improved 
slowly until the time of surgery. Also, no obvious morpho-
logical aspects of an acute etiology (e.g. perforated or flail 
mitral leaflet) were observed during the preoperative and 
intraoperative echocardiography exams. Therefore, despite 
some leaflet thickening, a secondary etiology of MR 
appeared likely, supported by the lack of coaptation and the 
dilated LV. Severe primary AR certainly increased LV vol-
ume load, and hence, LV preload. Echocardiographic grad-
ing of MR in this patient was thus based on guidelines for 
chronic secondary MR.4 A classification into “acute or 
Figure 3. Intraoperative transesophageal echocardiography 
(TEE) with pre-surgical continuous wave (CW) Doppler profile of 
the mitral regurgitation jet.
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“chronic” MR, as given in recent recommendations, was dif-
ficult due to progression of severity over days, particularly 
since there appear to be no exact time frame definitions for 
“acute” or “chronic.”4,9,13
General anesthesia is well known to reduce severity of 
MR mainly by reducing LV afterload, which may lead 
intraoperatively to a relative underestimation of lesion 
grade. In contrast, in this case, MR was judged even more 
severe under anesthesia conditions. However, there is a 
difference in heart rate from the severe-grade initial intra-
operative TEE evaluation (heart rate 73/min) to the other 
echocardiographic evaluations of MR (HR 93–99/min) 
that may contribute to altered loading conditions, that is, to 
a larger regurgitant volume and hence a higher grade MR. 
The mVD will render echocardiographic grading of valvu-
lar lesion severity rather more complex owing to the hemo-
dynamic interaction of the lesions’ effects. For the 
combination of AR with MR, the recent literature recom-
mends the PISA method for grading of MR with calcula-
tion of EROA.6,7 Measurement of VC is also relatively 
independent from loading conditions.7 In secondary MR, 
two-dimensional VC and PISA measurements are prone to 
underestimating MR severity due to non-circularity of the 
regurgitant orifice (with its larger diameter along the coap-
tation line). Nevertheless, in this case, PISA and VC meas-
urements were clearly indicative of severe MR and were 
measured orthogonal to the coaptation line.4
Volume overload together with systolic hypertension will 
frequently induce eccentric hypertrophy of the LV. 
Subsequent dilatation of the LV may have worsened mild-to-
moderate MR by progressive symmetrical tethering of the 
systolic leaflet motion (Carpentier Class IIIb).
Given the Class I indication for surgical AVR in this case of 
IE, surgical treatment of the incidentally diagnosed severe-
grade secondary chronic MR would be considered reasonable 
by current guidelines,9,13 is supported by small retrospective 
series10,14 and a recent review,5 but has obviously been proven 
unnecessary in this patient. Echocardiographic re-evaluation 
of the MR during reperfusion on partial CPB support was pre-
dictive of immediate, substantial, and sustained improvement 
of MR after weaning. The chosen strategy of correcting the 
leading left-sided lesion first and only add TV repair as a brief 
beating-heart procedure, with reevaluation of the MV thereaf-
ter, turned out well and spared this multi-morbid patient a pro-
longation of the open-chamber procedure and her CPB time.
Conclusion
When deciding to extend surgery to another structurally 
intact valve, careful and multi-disciplinary consideration 
of individual pathophysiology is of utmost importance. 
This is even more important after intraoperative detection 
of additional lesions. Specifically determining the etiology 
of the separate lesions and their interaction is essential 
(independent, common, or dependent etiology). It also 
underlines the importance of a comprehensive and current 
preoperative and intraoperative echocardiographic work-
up particularly in patients with rapidly changing cardiac 
loading conditions and a fluctuating entity like functional 
MR.
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